Follow us on




Q of the week

Q: What are the possible benefits and risks of clinical trials?

Get the Answer: 

Invanz
Invanz is a once-daily injectable antibiotic approved for use in adults for the treatment of moderate to severe infections caused by common gram-positive and gram-negative aerobic and anaerobic bacteria. Included, are community-acquired pneumonia, intra-abdominal, skin, urinary tract, kidney and post-surgical gynecological infections.

Use of GCP HelpDesk’s resources

Copyright notice
All documents and information on the GCP Helpdesk website are protected under intellectual property law, in particular by copyright.

The documents and information are available free of charge for public information only.

Reproduction and distribution of documents or information in whatever form and by whatever medium (including Internet) is authorized, except for commercial purposes, provided that their source is acknowledged by mentioning:
· GCP HelpDesk
· the URL www.gcphelpdesk.com
· the fact that the documents and information have been provided free of charge by the GCP HelpDesk.


However, prior permission of GCP HelpDesk is needed for any adaptation or translation of the documents or information.

Links to the pages on this site are permitted provided that the browser window does not contain any information other than that of the page of the present site to which the link is made and its address and none of the information provided on this site is modified.

 
 


Opinion Poll

Which one of the following do you think is the most common reason for participating in clinical trials?
 
This opinion poll provides an informal way for the clinical research community to express its views on current topics. The results are not a scientific poll and do not necessarily reflect the percentages of all clinical researchers who agree with these positions.

Links